Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 0/6 |
Past Performance | 3/6 |
Financial Health | 5/6 |
Dividends | 3/6 |
4111 Stock Overview
Chi Sheng Pharma & Biotech Co., Ltd manufactures and distributes medical medicines and equipment in Taiwan and internationally.
Chi Sheng Pharma & Biotech Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | NT$23.40 |
52 Week High | NT$26.50 |
52 Week Low | NT$21.60 |
Beta | 0.24 |
1 Month Change | 1.52% |
3 Month Change | 3.31% |
1 Year Change | 2.86% |
3 Year Change | -8.42% |
5 Year Change | -2.91% |
Change since IPO | 75.16% |
Recent News & Updates
Read This Before Buying Chi Sheng Pharma & Biotech Co., Ltd (GTSM:4111) For Its Dividend
Could Chi Sheng Pharma & Biotech Co., Ltd ( GTSM:4111 ) be an attractive dividend share to own for the long haul...
Shareholder Returns
4111 | TW Pharmaceuticals | TW Market | |
---|---|---|---|
7D | 1.7% | 2.3% | 2.4% |
1Y | 2.9% | 4.7% | -12.5% |
Return vs Industry: 4111 underperformed the TW Pharmaceuticals industry which returned 4.7% over the past year.
Return vs Market: 4111 exceeded the TW Market which returned -12.5% over the past year.
Price Volatility
4111 volatility | |
---|---|
4111 Average Weekly Movement | 2.4% |
Pharmaceuticals Industry Average Movement | 4.8% |
Market Average Movement | 5.1% |
10% most volatile stocks in TW Market | 8.4% |
10% least volatile stocks in TW Market | 2.5% |
Stable Share Price: 4111 is less volatile than 75% of TW stocks over the past 3 months, typically moving +/- 2% a week.
Volatility Over Time: 4111's weekly volatility (2%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1962 | n/a | n/a | https://www.cscp.com.tw |
Chi Sheng Pharma & Biotech Co., Ltd manufactures and distributes medical medicines and equipment in Taiwan and internationally. Its products include antibiotics and chemotherapeutic agents; plasma substitutes and amino acid preparations; water nutrients and electrolyte preparations; vitamins; hepatotropic agents; hormones and adrenal cortical steroids; autonomic nerves agents; antihistamines and antipruritics; antipyretics and analgesics; antitussives and anti-asthmas; gastro-intestinal preparations; local anesthetic preparations; hemodialysis concentrate and external solutions; peritoneal dialysis solutions; and others. The company also offers medical devices, fat emulsion products, anesthetic products, hemostatics solutions, food products, health foods, functional drinks, skin care products, cosmetics, and veterinary medicinal products.
Chi Sheng Pharma & Biotech Co., Ltd Fundamentals Summary
4111 fundamental statistics | |
---|---|
Market Cap | NT$1.33b |
Earnings (TTM) | NT$94.15m |
Revenue (TTM) | NT$1.08b |
14.2x
P/E Ratio1.2x
P/S RatioIs 4111 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
4111 income statement (TTM) | |
---|---|
Revenue | NT$1.08b |
Cost of Revenue | NT$712.45m |
Gross Profit | NT$372.02m |
Other Expenses | NT$277.87m |
Earnings | NT$94.15m |
Last Reported Earnings
Mar 31, 2022
Next Earnings Date
n/a
Earnings per share (EPS) | 1.65 |
Gross Margin | 34.30% |
Net Profit Margin | 8.68% |
Debt/Equity Ratio | 11.5% |
How did 4111 perform over the long term?
See historical performance and comparisonDividends
4.3%
Current Dividend Yield61%
Payout RatioDoes 4111 pay a reliable dividends?
See 4111 dividend history and benchmarksChi Sheng Pharma & Biotech dividend dates | |
---|---|
Ex Dividend Date | Aug 22 2022 |
Dividend Pay Date | Sep 23 2022 |
Days until Ex dividend | 11 days |
Days until Dividend pay date | 43 days |
Does 4111 pay a reliable dividends?
See 4111 dividend history and benchmarks